Snowball logo
logo
PHGN_logo

Pharming Group NV

€1.0435+€0.1095Β  (11.72%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
167.7205.6245.3297.2376.1366.4
COGS
17.8317.5625.2135.445.549.36
Gross Profit
149.9188.1220.1261.8330.6317.1
Operating Expenses & Income
Operating Income
11.4418.23(22.29)(3.665)20.8812.35
Total Operating Expenses
156.2187.4267.6300.9355.3354.1
R&D Expenses
59.3352.5368.9183.15100.4113.3
Selling General & Admin Expenses
81.3131.887.599.22117.4191.4
Earnings from Continuing Operations
Interest Expense
(6.091)(5.358)(5.964)(8.737)(10.72)(14.72)
Interest Income
12.570.0853.6634.8582.1765.143
Income Tax Expense
7.0821.313----
Net Income
Net Income
13.4913.67(10.55)(11.84)2.8519.273
Supplemental
EBIT
246.033(6.048)0.24523.5730.56
EBITDA
41.2231.429.87716.3234.7842.65
In millions of EUR, except % and values per 1 share